The Loss of Radiographic Enhancement in Primary Renal Cell Carcinoma Tumors Following Multitargeted Receptor Tyrosine Kinase Therapy is an Additional Indicator of Response
To access this article, please choose from the options below
This study was supported by the Doris Duke Charitable Foundation (WKR) and the UNC Hematology T32 training grant (CLC).
Julia R. Fielding and W. Kimryn Rathmell are co-corresponding authors.
PII: S0090-4295(09)02392-9
doi:10.1016/j.urology.2009.06.105
© 2010 Elsevier Inc. All rights reserved.
